Editas Medicine(EDIT) - 2023 Q4 - Earnings Call Transcript

Editas Medicine, Inc. (NASDAQ:EDIT) Q4 2023 Earnings Conference Call February 28, 2024 8:00 AM ET Company Participants Cristi Barnett - Corporate Communications and IR Gilmore O'Neill - CEO Baisong Mei - CMO Erick Lucera - CFO Linda Burkly - CSO Caren Deardorf - Chief Commercial and Strategy Officer Conference Call Participants Joon Lee - Truist Securities Samantha Semenkow - Citi Brian Cheng - JPMorgan Greg Harrison - Bank of America Mani Foroohar - Leerink Max Skor - Morgan Stanley Gena Wang - Barclays Da ...